Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

IL-33 anticorps

Il existe 1 publication pour ce produit. L’anticorps anti-IL-33 Polyclonal Lapin est utilisé pour la détection de IL-33 dans des échantillons de Humain. Il a été validé pour WB, IHC et ELISA.
N° du produit ABIN1169165
275,12 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 2 à 5 jours ouvrables

Aperçu rapide pour IL-33 anticorps (ABIN1169165)

Antigène

Voir toutes IL-33 (IL33) Anticorps
IL-33 (IL33) (Interleukin 33 (IL33))

Reactivité

  • 97
  • 81
  • 54
  • 9
  • 1
Humain

Hôte

  • 142
  • 38
  • 8
  • 2
  • 1
  • 1
Lapin

Clonalité

  • 139
  • 53
Polyclonal

Conjugué

  • 91
  • 24
  • 16
  • 8
  • 8
  • 8
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp IL-33 est non-conjugé

Application

  • 114
  • 70
  • 62
  • 53
  • 26
  • 25
  • 15
  • 15
  • 11
  • 9
  • 9
  • 6
  • 5
  • 5
  • 4
  • 4
  • 3
  • 2
  • 2
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), ELISA
  • Fonction

    anti-IL-33 (human), pAb

    Specificité

    Recognizes human IL-33. Detects a band of ~18 kDa by Western blot.

    Attributs du produit

    Polyclonal Antibody. Recognizes human IL-33. Detects a band of ~18 kDa by Western blot. Source: Rabbit. Applications: ELISA, IHC, WB. Liquid. 0.2μm-filtered solution in PBS, pH 7.4. Contains no preservatives. Interleukin-33 (IL-33, HF-NEV, IL-1F11), a member of the IL-1 family of cytokines, is expressed by many cell types following pro-inflammatory stimulation and is thought to be released on cell lysis. The 30 kDa human IL33 is converted by CASP1 to a 18 kDa protein. IL33 binds to and signals through ST2 (IL1R1) and its stimulation recruits MYD88, IRAK, IRAK4, and TRAF6, followed by phosphorylation of ERK1(MAPK3)/ERK2(MAPK1), p38(MAPK14), and JNK. The ability of IL-33 to target numerous immune cell types, like Th2-like cells, mast cells, and B1 cells, and to induce cytokine and chemokine production underlines its potential in influencing the outcome of a wide range of diseases, such as arthritis, asthma, atopic allergy & anaphylaxis, cardiovascular disease/atherosclerosis, nervous system diseases, and sepsis.

    Stérilité

    0.2 μm filtered

    Immunogène

    Recombinant human IL-33.
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    0.2μm-filtered solution in PBS, pH 7.4.

    Agent conservateur

    Without preservative

    Conseil sur la manipulation

    After opening, prepare aliquots and store at -20 °C.Avoid freeze/thaw cycles.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    +4°C

    -20°C

    Stable for at least 6 months after receipt when stored at -20°C.

    Date de péremption

    6 months
  • Carriere, Roussel, Ortega, Lacorre, Americh, Aguilar, Bouche, Girard: "IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, Issue 1, pp. 282-7, (2007) (PubMed).

  • Antigène

    IL-33 (IL33) (Interleukin 33 (IL33))

    Autre désignation

    IL-33

    Sujet

    Alternate Names/Synonyms: Interleukin-33, IL-1F11, NF-HEV

    Product Description: Interleukin-33 (IL-33, HF-NEV, IL-1F11), a member of the IL-1 family of cytokines, is expressed by many cell types following pro-inflammatory stimulation and is thought to be released on cell lysis. The 30 kDa human IL33 is converted by CASP1 to a 18 kDa protein. IL33 binds to and signals through ST2 (IL1R1) and its stimulation recruits MYD88, IRAK, IRAK4, and TRAF6, followed by phosphorylation of ERK1(MAPK3)/ERK2(MAPK1), p38(MAPK14), and JNK. The ability of IL-33 to target numerous immune cell types, like Th2-like cells, mast cells, and B1 cells, and to induce cytokine and chemokine production underlines its potential in influencing the outcome of a wide range of diseases, such as arthritis, asthma, atopic allergy & anaphylaxis, cardiovascular disease/atherosclerosis, nervous system diseases, and sepsis.

    UniProt

    O95760

    Pathways

    Production of Molecular Mediator of Immune Response
Vous êtes ici:
Chat with us!